Brief: Scilex Holding Company Announces Completion Of Commercial Manufacturing Of Gloperba®, Expecting U.S. Launch In The First Quarter Of 2024
Nov 27 (Reuters) - Scilex Holding Co SCLX.O :
* SCILEX HOLDING COMPANY ANNOUNCES COMPLETION OF COMMERCIAL
MANUFACTURING OF GLOPERBA® WITH THE BRAND MARKETED AND
DISTRIBUTED UNDER SCILEX PHARMACEUTICALS, INC. AND IS EXPECTING
TO LAUNCH IN THE U.S. IN THE FIRST QUARTER OF 2024
Source text for Eikon: ID:nGNX3LCZQT
Further company coverage: SCLX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scilex Holding
See all newsEnters Promissory Note With Vivasor For Revolving Credit Up To $20 Million, On Aug 8
Brief: Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens To List On Biconomy Exchange As Early As June 23, 2026
Brief: O+C Private Credit Wade Defendants Dispute Complaint And Statement By Scilex Holding Company
Company Enters Binding Term Sheet With Datavault Ai - SEC Filing
Company May Offer Up To $500 Million In Securities - SEC Filing